ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.890
+0.030 (1.61%)
Sep 17, 2026, 4:00 PM EDT - Market closed
ProQR Therapeutics Market Cap
ProQR Therapeutics has a market cap or net worth of $266.72 million as of September 17, 2026. Its market cap has increased by 24.46% in one year.
Market Cap
266.72M
Enterprise Value
150.40M
1-Year Change
24.46%
Ranking
Category
Stock Price
$1.89
ChartMarket Cap Chart
Since September 18, 2014, ProQR Therapeutics's market cap has decreased from $308.80M to $266.72M, a decrease of -13.63%. That is a compound annual growth rate of -1.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 203.60M | -6.43% |
| Dec 31, 2025 | 217.60M | -2.55% |
| Dec 31, 2024 | 223.30M | 33.87% |
| Dec 29, 2023 | 166.80M | -39.78% |
| Dec 30, 2022 | 277.00M | -53.81% |
| Dec 31, 2021 | 599.70M | 164.07% |
| Dec 31, 2020 | 227.10M | -46.89% |
| Dec 31, 2019 | 427.60M | -15.11% |
| Dec 31, 2018 | 503.70M | 568.92% |
| Dec 29, 2017 | 75.30M | -34.18% |
| Dec 30, 2016 | 114.40M | -43.53% |
| Dec 31, 2015 | 202.60M | -55.40% |
| Dec 31, 2014 | 454.30M | 47.12% |
| Sep 18, 2014 | 308.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 278.58M |
| Lineage Cell Therapeutics | 270.61M |
| AC Immune | 264.48M |
| Lyell Immunopharma | 264.04M |
| YD Bio | 260.18M |
| MacroGenics | 259.90M |
| Sutro Biopharma | 258.67M |
| Bicycle Therapeutics | 255.12M |